Skip to main content
. 2010 Jun 14;33(9):2065–2067. doi: 10.2337/dc10-0460

Table 1.

Unadjusted and adjusted mean CD36 mRNA/protein and Pearson product moment correlations (r)

CD36 mRNA (log r.u.) CD36 protein (log r.u.)
Type 2 diabetes Nondiabetic control subjects Type 2 diabetes Nondiabetic control subjects
n 33 27 33 27
Unadjusted mean 0.23 ± 0.02 0.16 ± 0.02 0.28 ± 0.02§ 0.18 ± 0.02
Model 1 0.21 ± 0.02 0.17 ± 0.02 0.27 ± 0.01* 0.21 ± 0.02
Model 2 0.20 ± 0.02 0.18 ± 0.02 0.26 ± 0.01 0.20 ± 0.01
CD36 mRNA (log r.u.) NA NA r = 0.64 r = 0.63
PPAR-γ mRNA (log r.u.) r = 0.73 r = 0.72 r = 0.33# r = 0.46*
hsCRP (log mg/dl) r = 0.55 r = 0.21 r = 0.45 r = 0.43*
hsIL-6 (log pg/ml) r = 0.40* r = 0.49 r = 0.64 r = 0.49
TNF-α (log pg/ml) r = −0.20 r = 0.09 r = −0.28 r = −0.02
Adiponectin (log μg/ml) r = −0.61 r = −0.67 r = −0.60 r = −0.56
BMI (kg/m2) r = 0.20 r = 0.03 r = 0.09 r = 0.17
HOMA-IR (log r.u.) r = 0.18 r = 0.03 r = 0.12 r = −0.07
QUICKI (log r.u.) r = −0.20 r = 0.05 r = −0.16 r = 0.19

Data are least squares means ± SEM unless otherwise indicated. The P value is from a t test of equality of the means. Model 1 adjusts for hypertension (HTN), hsIL-6, PPAR, adiponectin, and QUICKI. Model 2 adjusts for hsIL-6, adiponectin, and QUICKI.

*P < 0.05,

P < 0.01,

P < 0.001,

§P < 0.0001,

#P = 0.08. HOMA-IR, homeostasis model assessment–insulin resistance; QUICKI, quantitative insulin sensitivity check index; r.u., relative units.